Company Filing History:
Years Active: 2009-2016
Title: Yulia Tyurina: Innovator in Mitochondrial Targeting Agents
Introduction
Yulia Tyurina is a prominent inventor based in Pittsburgh, PA (US). She has made significant contributions to the field of biomedical research, particularly in the development of selective targeting agents for mitochondria. With a total of 4 patents to her name, her work focuses on innovative solutions for treating illnesses associated with cellular damage.
Latest Patents
One of Yulia's latest patents involves the creation of selective targeting agents for mitochondria. This invention provides a composition and related methods for delivering cargo to mitochondria, which includes a membrane-active peptidyl fragment with a high affinity for mitochondria and the desired cargo. The cargo can be selected from a variety of substances intended for specific purposes. The patent discusses compositions and methods for treating illnesses caused by excessive mitochondrial production of reactive oxygen species (ROS). By utilizing structural signaling recognizable by cells as mitochondrial targeting sequences, her compositions inhibit cell death by apoptosis through ROS-scavenging activity, thereby increasing patient survival rates.
Career Highlights
Yulia Tyurina is affiliated with the University of Pittsburgh, where she continues her research and development efforts. Her innovative work has positioned her as a key figure in the field of mitochondrial research, contributing to advancements that have the potential to improve patient outcomes.
Collaborations
Yulia collaborates with esteemed colleagues such as Peter Wipf and Jingbo Xiao, enhancing the impact of her research through teamwork and shared expertise.
Conclusion
Yulia Tyurina's contributions to the field of mitochondrial targeting agents exemplify her dedication to innovation in biomedical research. Her work not only advances scientific understanding but also holds promise for improving therapeutic strategies for various illnesses.